Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

[Long-term survival with complete response by gefitinib treatment followed by noncurative operation for lung cancer].

Fukaya K, Tabata T, Minowa M, Katsumata H, Fujimura S.

Kyobu Geka. 2014 May;67(5):375-8. Japanese.

PMID:
24917282
2.

[A case of postoperative recurrent lung cancer with long survival due to gefitinib efficacy].

Okagawa T, Uchida T, Suyama M.

Gan To Kagaku Ryoho. 2007 Nov;34(11):1841-3. Japanese.

PMID:
18030020
3.

[Long survival case of resected lung cancer after chemotherapy with gefitinib].

Kato H, Oizumi H, Watarai H, Sadahiro M.

Kyobu Geka. 2013 Aug;66(9):818-21. Japanese.

PMID:
23917236
4.

[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib].

Yanagitani N, Horiike A, Kudo K, Ohyanagi F, Nishio M, Horai T.

Nihon Kokyuki Gakkai Zasshi. 2011 Apr;49(4):282-6. Japanese.

PMID:
21591457
5.

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, Hatooka S, Shinoda M, Takahashi T, Yatabe Y.

J Clin Oncol. 2005 Apr 10;23(11):2513-20. Epub 2005 Feb 28.

PMID:
15738541
6.

Gallbladder cancer with tumor thrombus in the superior vena cava.

Batra S, Doval DC, Batra U, Suresh P, Dhiman A, Talwar V.

Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):325-8.

7.

[A case of non-small cell lung cancer with EGFR mutation responding to S-1 after a therapy with gefitinib].

Kawano O, Yano M, Sasaki H, Yukiue H, Okuda K, Fujii Y.

Gan To Kagaku Ryoho. 2009 Apr;36(4):675-7. Japanese.

PMID:
19381047
9.

Long-term effect of gefitinib (ZD1839) on squamous cell carcinoma of the lung.

Kozuki T, Kiura K, Ueoka H, Tabata M, Date H, Hamazaki S, Bessho A, Tanimoto M.

Anticancer Res. 2004 Jan-Feb;24(1):393-6.

10.

Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery.

Kondo M, Yokoyama T, Fukui T, Yoshioka H, Yokoi K, Nagasaka T, Imaizumi K, Kume H, Hasegawa Y, Shimokata K, Sekido Y.

Lung Cancer. 2005 Dec;50(3):385-91. Epub 2005 Sep 2.

PMID:
16140420
11.

Complete metabolic remission with Gefitinib in a hemodialysis patient with bone metastases from non-small cell lung cancer.

Del Conte A, Minatel E, Schinella D, Baresic T, Basso SM, Lumachi F.

Anticancer Res. 2014 Jan;34(1):319-22.

PMID:
24403481
12.

Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer.

Chang JW, Chou CL, Huang SF, Wang HM, Hsieh JJ, Hsu T, Cheung YC.

Lung Cancer. 2007 Dec;58(3):414-7. Epub 2007 Jul 6.

PMID:
17618013
13.

[A case of lung adenocarcinoma wtih exon19 and T790M mutations in EGFR having good response to erlotinib after gefitinib treatment failure].

Tanaka H, Okamoto T, Shinyama M, Matsumura S, Fujii T.

Gan To Kagaku Ryoho. 2013 Aug;40(8):1067-9. Japanese.

PMID:
23986053
14.

Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report.

Ko HW, Tsai YH, Yu CT, Huang CY, Chen CH.

Chang Gung Med J. 2008 Nov-Dec;31(6):606-11.

15.

Salvage surgery for a super-responder by gefitinib therapy for advanced lung cancer.

Hashimoto K, Horinouchi H, Ohtsuka T, Kohno M, Izumi Y, Hayashi Y, Nomori H.

Gen Thorac Cardiovasc Surg. 2012 Dec;60(12):851-4. doi: 10.1007/s11748-012-0087-2. Epub 2012 Jun 12.

PMID:
22688581
17.

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer.

Sasaki H, Endo K, Okuda K, Kawano O, Kitahara N, Tanaka H, Matsumura A, Iuchi K, Takada M, Kawahara M, Kawaguchi T, Yukiue H, Yokoyama T, Yano M, Fujii Y.

J Cancer Res Clin Oncol. 2008 May;134(5):569-77. Epub 2007 Oct 12.

PMID:
17932690
18.

[A case of advanced adenocarcinoma of the lung which maintained complete response for 5 years by treatment with gefitinib].

Matsuzaki T, Terashima T, Ogawa R, Naitou A, Miyauchi J, Morishita T.

Nihon Kokyuki Gakkai Zasshi. 2010 Aug;48(8):600-3. Japanese.

PMID:
20803978
19.

Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.

Fukuhara T, Saijo Y, Sakakibara T, Inoue A, Morikawa N, Kanamori M, Nakashima I, Nukiwa T.

Tohoku J Exp Med. 2008 Apr;214(4):359-63.

20.

Surgical resection of locally advanced epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma after gefitinib and review of the literature.

Marech I, Vacca A, Gnoni A, Silvestris N, Lorusso V.

Tumori. 2013 Sep-Oct;99(5):e241-4. doi: 10.1700/1377.15324. Review.

PMID:
24362878

Supplemental Content

Support Center